Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction.
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback